Microbix Biosystems Inc. (TSX: MBX)
Canada
· Delayed Price · Currency is CAD 0.335
+0.010 (3.08%)
Jul 19, 2024, 1:35 PM EDT
Microbix Biosystems Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Year Ending | TTM | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 23.84 | 16.51 | 19.08 | 18.59 | 10.52 | 13.41 | Upgrade
|
| Revenue Growth (YoY) | 48.41% | -13.43% | 2.60% | 76.66% | -21.53% | 7.21% | Upgrade
|
| Cost of Revenue | 10.87 | 9.03 | 7.95 | 7.55 | 5.86 | 6.86 | Upgrade
|
| Gross Profit | 12.96 | 7.48 | 11.12 | 11.04 | 4.66 | 6.55 | Upgrade
|
| Selling, General & Admin | 9.51 | 8.17 | 6.72 | 5.17 | 4.17 | 4.4 | Upgrade
|
| Research & Development | 2.08 | 2.05 | 1.8 | 1.03 | 1.01 | 1.04 | Upgrade
|
| Operating Expenses | 11.59 | 10.22 | 8.51 | 6.21 | 5.19 | 5.44 | Upgrade
|
| Operating Income | 1.37 | -2.74 | 2.61 | 4.84 | -0.52 | 1.11 | Upgrade
|
| Interest Expense | -0.91 | -0.84 | -0.83 | -1.6 | -1.06 | -1.07 | Upgrade
|
| Interest & Investment Income | 0.52 | 0.46 | 0.08 | 0 | - | - | Upgrade
|
| Net Interest Expenses | -0.39 | -0.38 | -0.74 | -1.6 | -1.06 | -1.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 0.98 | -3.12 | 1.87 | 3.23 | -1.58 | 0.04 | Upgrade
|
| Asset Writedown | 3.08 | 3.08 | - | - | -3.08 | - | Upgrade
|
| Pretax Income | 4.06 | -0.04 | 1.87 | 3.23 | -4.66 | 0.04 | Upgrade
|
| Income Tax Expense | - | - | 0.08 | - | 1.57 | 0.01 | Upgrade
|
| Net Income | 4.06 | -0.04 | 1.79 | 3.23 | -6.23 | 0.03 | Upgrade
|
| Net Income to Common | 4.06 | -0.04 | 1.79 | 3.23 | -6.23 | 0.03 | Upgrade
|
| Net Income Growth | - | - | -44.68% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 137 | 138 | 135 | 115 | 105 | 97 | Upgrade
|
| Shares Outstanding (Diluted) | 138 | 138 | 142 | 142 | 105 | 97 | Upgrade
|
| Shares Change (YoY) | -0.36% | -2.67% | 0.00% | 35.14% | 7.99% | 0.92% | Upgrade
|
| EPS (Basic) | 0.03 | -0.00 | 0.01 | 0.03 | -0.06 | 0.00 | Upgrade
|
| EPS (Diluted) | 0.03 | -0.00 | 0.01 | 0.03 | -0.06 | 0.00 | Upgrade
|
| EPS Growth | - | - | -49.98% | - | - | - | Upgrade
|
| Free Cash Flow | 1.85 | -2.11 | 1.44 | 0.86 | -0.8 | -0.39 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.02 | 0.01 | 0.01 | -0.01 | -0.00 | Upgrade
|
| Gross Margin | 54.38% | 45.30% | 58.32% | 59.40% | 44.28% | 48.82% | Upgrade
|
| Operating Margin | 5.76% | -16.57% | 13.68% | 26.01% | -4.98% | 8.27% | Upgrade
|
| Profit Margin | 17.04% | -0.24% | 9.38% | 17.39% | -59.17% | 0.24% | Upgrade
|
| Free Cash Flow Margin | 7.74% | -12.78% | 7.55% | 4.65% | -7.64% | -2.90% | Upgrade
|
| EBITDA | 2.3 | -1.9 | 3.33 | 5.39 | -0.1 | 1.54 | Upgrade
|
| EBITDA Margin | 9.64% | -11.48% | 17.45% | 28.97% | -0.91% | 11.48% | Upgrade
|
| D&A For EBITDA | 0.93 | 0.84 | 0.72 | 0.55 | 0.43 | 0.43 | Upgrade
|
| EBIT | 1.37 | -2.74 | 2.61 | 4.84 | -0.52 | 1.11 | Upgrade
|
| EBIT Margin | 5.75% | -16.57% | 13.68% | 26.01% | -4.98% | 8.27% | Upgrade
|
| Effective Tax Rate | - | - | 4.14% | - | - | 26.93% | Upgrade
|
| Revenue as Reported | 23.84 | 16.51 | 19.08 | 18.59 | 10.52 | 13.41 | Upgrade
|
Source: S&P Capital IQ. Standard template.